{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:58:51Z","timestamp":1790870331442,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.hlc.2022.08.002","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T22:31:43Z","timestamp":1663626703000},"page":"1450-1462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Prevalence and Risk Factors of Cardiac Amyloidosis in Heart Failure: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"31","author":[{"given":"Alicia Su Yun","family":"See","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie Sin-Ying","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoke Ching","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiong-Cheng","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond C.C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8319-504X","authenticated-orcid":false,"given":"Weiqin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2764-2869","authenticated-orcid":false,"given":"Ching-Hui","family":"Sia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.hlc.2022.08.002_bib1","first-page":"178","article-title":"Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management","volume":"32","author":"Hassan","year":"2005","journal-title":"Tex Heart Inst J"},{"issue":"8","key":"10.1016\/j.hlc.2022.08.002_bib2","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.hlc.2022.08.002_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tcm.2017.07.004","article-title":"Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment","volume":"28","author":"Siddiqi","year":"2018","journal-title":"Trends Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.hlc.2022.08.002_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005407","article-title":"Epidemiology of Cardiac Amyloidosis-Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States","volume":"12","author":"Gilstrap","year":"2019","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.hlc.2022.08.002_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s11864-020-00738-8","article-title":"Advances in the Treatment of Cardiac Amyloidosis","volume":"21","author":"Macedo","year":"2020","journal-title":"Curr Treat Options Oncol"},{"issue":"8","key":"10.1016\/j.hlc.2022.08.002_bib6","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.cardfail.2019.07.197","article-title":"Amyloidosis Research Consortium Cardiac Amyloidosis Survey: Results from Patients with AL and ATTR Amyloidosis and Their Caregivers","volume":"25","author":"Lousada","year":"2019","journal-title":"J\u00a0Card Fail"},{"issue":"22","key":"10.1016\/j.hlc.2022.08.002_bib7","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.hlc.2022.08.002_bib8","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1001\/archinte.166.17.1805","article-title":"Amyloidosis and the heart: a comprehensive review","volume":"166","author":"Shah","year":"2006","journal-title":"Arch Intern Med"},{"issue":"13","key":"10.1016\/j.hlc.2022.08.002_bib9","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and management of the cardiac amyloidoses","volume":"112","author":"Falk","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2022.08.002_bib10","first-page":"12","article-title":"Excluding small studies from a systematic review or meta-analysis","author":"Grainge","year":"2015","journal-title":"InCSG Annual Meeting"},{"issue":"2","key":"10.1016\/j.hlc.2022.08.002_bib11","first-page":"60","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"Evid Based Med"},{"issue":"9","key":"10.1016\/j.hlc.2022.08.002_bib12","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10554-016-0915-z","article-title":"Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy","volume":"32","author":"Bennani Smires","year":"2016","journal-title":"Int J Card Imaging"},{"issue":"4","key":"10.1016\/j.hlc.2022.08.002_bib13","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1002\/ehf2.13360","article-title":"Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy","volume":"8","author":"Devesa","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"3","key":"10.1016\/j.hlc.2022.08.002_bib14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.mayocp.2018.07.025","article-title":"Utility of the Serum Free Light Chain Assay in the Diagnosis of Light Chain Amyloidosis in Patients With Heart Failure","volume":"94","author":"Chang","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"sup1","key":"10.1016\/j.hlc.2022.08.002_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/13506129.2019.1582502","article-title":"Transthyretin amyloidosis in patients with undifferentiated heart failure","volume":"26","author":"Chang","year":"2019","journal-title":"Amyloid"},{"issue":"9","key":"10.1016\/j.hlc.2022.08.002_bib16","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jchf.2020.04.007","article-title":"Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis","volume":"8","author":"Hahn","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10.1016\/j.hlc.2022.08.002_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","article-title":"Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction","volume":"2","author":"Mohammed","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"9","key":"10.1016\/j.hlc.2022.08.002_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003352","article-title":"Afro-Caribbean heart failure in the United Kingdom","volume":"9","author":"Dungu","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.hlc.2022.08.002_bib19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/ehf2.13110","article-title":"Prevalence of wild type transtyrethin cardiac amyloidosis in a heart failure clinic","volume":"8","author":"Lindmark","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"3","key":"10.1016\/j.hlc.2022.08.002_bib34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/13506129.2019.1625322","article-title":"Prevalence of cardiac amyloidosis among elderly patients with systolic\u00a0heart failure or conduction disorders","volume":"26","author":"L\u00f3pez-Sainz \u00c1","year":"2019","journal-title":"Amyloid"},{"issue":"4","key":"10.1016\/j.hlc.2022.08.002_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/HPC.0000000000000183","article-title":"Transthyretin Cardiac Amyloidosis as Diagnosed by 99mTc-PYP Scanning in Patients with Acute Heart Failure and Preserved Ejection Fraction","volume":"18","author":"Lo Presti","year":"2019","journal-title":"Crit Pathw Cardiol"},{"issue":"24","key":"10.1016\/j.hlc.2022.08.002_bib41","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","article-title":"Clinical characteristics of wild-type transthyretin cardiac amyloidosis: Disproving myths","volume":"38","author":"Gonz\u00e1lez-L\u00f3pez","year":"2017","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.hlc.2022.08.002_bib20","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hlc.2022.08.002_bib21","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jcmg.2020.03.010","article-title":"Native T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac Amyloidosis: A Meta-Analysis","volume":"13","author":"Pan","year":"2020","journal-title":"JACC Cardiovasc Imag"},{"issue":"4","key":"10.1016\/j.hlc.2022.08.002_bib22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00392-020-01771-1","article-title":"Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study","volume":"110","author":"Chatzantonis","year":"2021","journal-title":"Clin Res Cardiol"},{"issue":"24","key":"10.1016\/j.hlc.2022.08.002_bib23","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.hlc.2022.08.002_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11886-019-1180-2","article-title":"Cardiac Amyloidosis: Updates in Imaging","volume":"21","author":"Chacko","year":"2019","journal-title":"Curr Cardiol Rep"},{"issue":"5","key":"10.1016\/j.hlc.2022.08.002_bib25","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/ehf2.12511","article-title":"Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis","volume":"6","author":"Brownrigg","year":"2019","journal-title":"ESC Heart Fail"},{"issue":"11","key":"10.1016\/j.hlc.2022.08.002_bib26","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","article-title":"Utility and limitations of 3,3-diphosphono-1, 2-propanodicarboxylic acid scintigraphy in systemic amyloidosis","volume":"15","author":"Hutt","year":"2014","journal-title":"Eur Heart J Cardiovasc Imag"},{"issue":"1","key":"10.1016\/j.hlc.2022.08.002_bib27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jaccao.2019.08.002","article-title":"Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management","volume":"1","author":"Witteles","year":"2019","journal-title":"JACC CardioOncol"},{"issue":"11","key":"10.1016\/j.hlc.2022.08.002_bib28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s12471-019-1299-1","article-title":"Cardiac amyloidosis: the need for early diagnosis","volume":"27","author":"Oerlemans","year":"2019","journal-title":"Neth Heart J"},{"issue":"3","key":"10.1016\/j.hlc.2022.08.002_bib29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCULATIONAHA.117.031560","article-title":"Prognostic value of high-sensitivity troponin T in chronic heart failure an individual patient data meta-analysis","volume":"137","author":"Aimo","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hlc.2022.08.002_bib30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrcardio.2013.129-c1","article-title":"Troponins in cardiac amyloidosis: Multipurpose markers","volume":"11","author":"Perfetto","year":"2014","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"10.1016\/j.hlc.2022.08.002_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/13506120903421538","article-title":"Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis","volume":"16","author":"Lehrke","year":"2009","journal-title":"Amyloid"},{"issue":"17","key":"10.1016\/j.hlc.2022.08.002_bib32","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1177\/2047487319877708","article-title":"Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings","volume":"27","author":"Vergaro","year":"2020","journal-title":"Eur J Prevent Cardiol"},{"issue":"3","key":"10.1016\/j.hlc.2022.08.002_bib33","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s10554-020-02059-1","article-title":"Indexed left ventricular mass to QRS voltage ratio is associated with heart failure hospitalizations in patients with cardiac amyloidosis","volume":"37","author":"Slivnick","year":"2021","journal-title":"Int J Cardiovasc Imag"},{"issue":"5","key":"10.1016\/j.hlc.2022.08.002_bib35","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jjcc.2015.11.004","article-title":"Clinical correlates and prognostic values of\u00a0pseudoinfarction in cardiac light-chain amyloidosis","volume":"68","author":"Zhao","year":"2016","journal-title":"J Cardiol"},{"issue":"1","key":"10.1016\/j.hlc.2022.08.002_bib36","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1038\/s41598-019-44245-9","article-title":"Associations of Electrocardiographic Parameters with Left Ventricular Longitudinal Strain and Prognosis in Cardiac Light Chain Amyloidosis","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"issue":"19","key":"10.1016\/j.hlc.2022.08.002_bib37","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.hlc.2022.08.002_bib39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10741-019-09796-z","article-title":"Speckle tracking echocardiography in cardiac amyloidosis","volume":"24","author":"Stricagnoli","year":"2019","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.hlc.2022.08.002_bib40","first-page":"2021","article-title":"Cardiac amyloidosis presenting as biventricular systolic heart failure","author":"Oye","year":"2021","journal-title":"Case Rep Cardiol"},{"issue":"13","key":"10.1016\/j.hlc.2022.08.002_bib42","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidoses: Disease profiles and clinical courses of the 3 main types","volume":"120","author":"Rapezzi","year":"2009","journal-title":"Circulation"},{"issue":"38","key":"10.1016\/j.hlc.2022.08.002_bib43","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/eurheartj\/ehv328","article-title":"Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction","volume":"36","author":"Castan\u00f5","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2022.08.002_bib45","series-title":"Risk factors for heart failure: 20-year population-based trends by sex, socioeconomic status, and ethnicity","author":"Lawson","year":"2020"},{"issue":"9","key":"10.1016\/j.hlc.2022.08.002_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","article-title":"Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis","volume":"12","author":"Maurer","year":"2019","journal-title":"Circ Heart Fail"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950622010496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950622010496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:07:23Z","timestamp":1761415643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950622010496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1443950622010496"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2022.08.002","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and Risk Factors of Cardiac Amyloidosis in Heart Failure: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2022.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}